Form 4 Tracker
Charles W Newhall III

Director · 2 filings · Latest: Feb 24, 2026

SUPERNUS PHARMACEUTICALS, INC.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
SUPN
CHARLES NEWHALL—Oct 9, 2025
Proposed Sale
$48.0025,000$1.2M—
SUPN
CHARLES NEWHALL—Aug 25, 2025
Proposed Sale
$44.884,588$205.9K—
SUPN
CHARLES NEWHALL—Aug 22, 2025
Proposed Sale
$43.321,412$61.2K—
SUPN
CHARLES NEWHALL—Nov 11, 2024
Proposed Sale
$36.2410,700$387.8K—